As of 31 Dec 2025, 30 institutional investors reported holding 2,851,427 shares of Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2,851,427 | $2,088,196 | -$35,774 | $0.71 | 30 |
| 2025 Q3 | 2,795,078 | $2,186,394 | +$67,244 | $0.75 | 28 |
| 2025 Q2 | 2,705,418 | $2,337,889 | +$320,116 | $0.88 | 27 |
| 2025 Q1 | 2,338,904 | $1,736,882 | +$874,783 | $0.75 | 23 |
| 2024 Q4 | 1,151,794 | $941,930 | +$711,698 | $0.88 | 12 |